A carregar...
The Effect of Sodium Channel Blocker, Mexiletine, on Body Weight in Type 2 Diabetes Patients with Visceral Obesity
OBJECTIVE: Mexiletine is an anti-arrhythmic agent also used for the treatment of painful diabetic neuropathy. In this study, the effect of mexiletine on body weight was evaluated in type 2 diabetes patients with diabetic neuropathy exhibiting visceral obesity. METHODS: Type 2 diabetes patients with...
Na minha lista:
| Publicado no: | Clin Med Insights Endocrinol Diabetes |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6343451/ https://ncbi.nlm.nih.gov/pubmed/30733634 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1179551418825049 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|